| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CELL.2018.09.038 |
| P698 | PubMed publication ID | 30343896 |
| P50 | author | Jason K Sa | Q63372484 |
| P2093 | author name string | Jing Chen | |
| Zhiliang Wang | |||
| Ying Zhang | |||
| Zheng Wang | |||
| Wei Zhang | |||
| Do-Hyun Nam | |||
| Yuqing Liu | |||
| Tao Jiang | |||
| Fan Wu | |||
| Wenbin Li | |||
| Xiaolong Fan | |||
| Zheng Zhao | |||
| Jiguang Wang | |||
| Zenghui Qian | |||
| Xiaoguang Qiu | |||
| Huimin Hu | |||
| Zhaoshi Bao | |||
| Fan Zeng | |||
| Chuanbao Zhang | |||
| Kuanyu Wang | |||
| Yiyun Chen | |||
| Biaobin Jiang | |||
| Qiangwei Wang | |||
| Yanwei Liu | |||
| Ruoyu Huang | |||
| Nam-Gu Her | |||
| Hee-Jin Cho | |||
| Quanhua Mu | |||
| Xun Kang | |||
| Yoonhee Nam | |||
| P2860 | cites work | Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas | Q27853175 |
| The somatic genomic landscape of glioblastoma | Q28300185 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 1665-1678.e18 | |
| P577 | publication date | 2018-10-18 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor | |
| P478 | volume | 175 |
| Q96575984 | A glioneuronal tumor with CLIP2-MET fusion |
| Q98164547 | ABCC8 mRNA expression is an independent prognostic factor for glioma and can predict chemosensitivity |
| Q64099560 | Brain Metastases from Lung Cancer: Is MET an Actionable Target? |
| Q89454515 | Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways |
| Q93013801 | Galectin-9: A Predictive Biomarker Negatively Regulating Immune Response in Glioma Patients |
| Q92542053 | Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses |
| Q91853984 | Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas |
| Q89966111 | Germ Cell-Specific Gene 1-Like Protein Regulated by Splicing Factor CUGBP Elav-Like Family Member 5 and Primary Bile Acid Biosynthesis are Prognostic in Glioblastoma Multiforme |
| Q92500797 | Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer |
| Q94236150 | Highlights from the Literature |
| Q91344849 | Intratumoral Susceptibility Signals Reflect Biomarker Status in Gliomas |
| Q91362810 | Longitudinal molecular trajectories of diffuse glioma in adults |
| Q92912403 | MET in glioma: signaling pathways and targeted therapies |
| Q98205062 | MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas |
| Q91652641 | Metabolic Reprogramming by c-MET Inhibition as a Targetable Vulnerability in Glioblastoma |
| Q92406903 | Molecular classification of IDH-mutant glioblastomas based on gene expression profiles |
| Q97543483 | Overexpression of HGF/MET axis along with p53 inhibition induces de novo glioma formation in mice |
| Q99240595 | Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma |
| Q64262027 | Predicting chromosome 1p/19q codeletion by RNA expression profile: a comparison of current prediction models |
| Q98939498 | Prognostic significance of ARL9 and its methylation in low-grade glioma |
| Q93198773 | Prognostic significance of age related genes in patients with lower grade glioma |
| Q92592923 | RNA processing genes characterize RNA splicing and further stratify lower-grade glioma |
| Q95841008 | Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma |
| Q98386349 | Stanniocalcin 1 is a prognostic biomarker in glioma |
| Q89666234 | Systematically Dissecting the Function of RNA-Binding Proteins During Glioma Progression |
| Q61800092 | Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities |
| Q64956698 | The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma. |
| Q96133082 | Upregulation of miR-340 Inhibits Tumor Growth and Mesenchymal Transition via Targeting c-MET in Glioblastoma |
Search more.